NCT06331013View on ClinicalTrials.gov

CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 20, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2029

Conditions
Prostate Cancer
Interventions
RADIATION

CyberKnife ultra-hypofractionated SBRT

CyberKnife ultra-hypofractionated SBRT for localized Prostate cancer with dose-escalation to the dominant intraprostatic lesion

Trial Locations (1)

Unknown

RECRUITING

European Institute of Oncology, Milan

All Listed Sponsors
lead

European Institute of Oncology

OTHER